Keywords: merger, charge, hits, pfizer, 2nd, quarter, deal

Merger charge hits Pfizer in 2nd quarter, but deal boosts revenues to near $10bn

Article | 04 August 2003

Print This

Pfizer, the world's leading drugmaker, has reported a $3.59 billion loss, or $0.48 per share, for the second quarter of 2003 as the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in